INTRODUCTION 45
Macrophages are important HIV-1 target cells in vivo (26, 40) . They can have a life span of 46 several weeks to months, patrol mucosal surfaces, infiltrate tissues at sites of inflammation and 47 7 First, we coexpressed Gag-CFP and HIV-1 Gag-iCFP not only with CD81-YFP but also with 141 CD4-YFP and TfR-YFP, which are unrelated membrane proteins. Second, we measured FRET 142 between a membrane localized control construct (MEM-CFP) and CD81-YFP, CD4-YFP and 143
TfR-YFP and third we cotransfected CFP with YFP or CD81-YFP (Fig. 3A) . Furthermore we 144 assessed expression of the Gag-CFP plasmid in macrophages which also resulted in formation of 145 VCCs (Fig. S3 ) Thus, HIV-1 Gag alone as well as in the presence of other viral proteins is 146 binding or in close proximity to CD81. This finding is in agreement with a recent study published 147 by the Ono lab (17) . 148
Next, we used an antibody directed against the extracellular region of CD81 to investigate if viral 149 assembly sites in general are accessible to antibodies. Staining was performed at 4 °C to reduce 150 membrane movement and phagocytosis. As expected, CD81 strongly colocalized (R=0.54) with 151
Gag in HIV-1 GG infected macrophages when cells were fixed and permeabilized prior to 152 staining ( Fig. 3B) . In contrast to this, only a minor population of Gag colocalized with CD81 153 (R=-0.12) when living macrophages were incubated with the CD81 antibody over a period of 60 154 minutes. Thus, the HIV-1 Gag containing assembly compartment is largely inaccessible to 155 antibodies at 4 °C. 156
In order to mimic the in vivo situation we additionally performed antibody feeding experiments at 157 37 °C with anti-HIV-1 GP120 antibodies (Fig. 4) . Living infected macrophages were incubated 158 with the same CD81 antibody as used previously, an antibody binding to but not inhibiting the 159 function of the Transferrin receptor (TfR) and additionally exposed to three broadly neutralizing 160 antibodies (2G12, VRC01, VRC03) directed against the CD4-binding site of HIV-1 GP120 (42, 161 46). When macrophages were fixed and permeabilized before staining, CD81 and GP120 showed 162 a pronounced pattern of colocalization with HIV-1 Gag (Fig. 4A, upper panel) . Conversely, no 163 colocalization could be observed when living macrophages were exposed to the antibodies for 60 164 on July 7, 2017 by guest http://jvi.asm.org/ Downloaded from 8 minutes at 37 °C (Fig. 4A, lower panel) . As antibody specificity control for Gag and CD81, as 165 well as Gag and GP120 colocalization we did the same experiment with a monoclonal anti-TfR 166 antibody (Fig. 4B) . TfR did not colocalize with Gag, neither in permeabilized nor living 167 macrophages, whereas Gag colocalized with GP120 only in case of permeabilization. These 168 results were confirmed and proven to be statistically highly significant by quantitative assessment 169 of the squared Pearson's correlation coefficient (R 2 -value) of the colocalizations from twentyfive 170 imaged macrophages (Fig. 4C) . Thus, macrophage internal HIV-1 is protected from recognition 171 by broadly neutralizing antibodies. 172
173
Efficient HIV-1 transfer from antibody treated macrophages to T-cells. It has been elegantly 174 demonstrated that macrophages transfer internal HIV-1 via virological synapses (VS) to T-cells 175 (13, 16) . Thus, we set up a functional experiment as described before (16) to test whether 176 treatment of macrophages with GP120 antibody inhibits the efficiency of HIV-1 transfer (Fig. 5) . 177
Addition of 20 μg/ml HIV-1 GP120 2G12 antibody (42) suppresses cell free infection of CemM7 178 T-cells nearly to background levels, whereas TfR-antibody had no blocking activity (Fig. 5A) . 179
Next, macrophages were infected for six days with R5-tropic HIV-1 expressing GFP via an IRES 180 element. Then infected macrophages were extensively washed and incubated for one hour at 37 181°C with TfR antibody or 2G12 to potentially neutralize macrophage internal HIV-1. Post 182 antibody removal, macrophages were cocultured for ten hours with CemM7 T-cells to allow cell-183 to-cell transfer of HIV-1. Then CemM7 T-cells were removed and cultured for another three to 184 four days for productive infection and reporter gene expression. Importantly, preincubation with 185 2G12 did not suppress the efficiency of macrophage internal HIV-1 to T-cells ( Importantly, since replication kinetics and peak viral titers were similar to untagged HIV-1, we 248 are confident that HIV-1 GG resembles the temporal and spatial Gag distribution of wild-type 249 HIV-1. This is important, since until now, the only tagged HIV-1 genome showing replication 250 and spread in primary macrophages was an HIV-1 AD8 variant with a tetracysteine (TC) tag 251 (13). While this is a useful and elegant tool, especially since the TC-tag does only have a minor 252 impact on virus infectivity, the need for biarsenic labelling hampers the possibility to image the 253 formation of newly synthesized Gag. 254
We followed up on Gag synthesis from immediately post-infection to up to four days. In contrast 255 to T-cells or 293T cells (18, 19, 22 ) the Gag precursor was not predominantly found at the plasma 256 membrane, but appeared in large perinuclear accumulations, which stayed stable for days (Fig.  257 2). HIV-1 containing compartments (VCCs) in macrophages have been described before (9, 21, 258 31, 33, 35) . However, their origin and fate remained elusive, because of the lack of a dynamic 259 on July 7, 2017 by guest http://jvi.asm.org/ Downloaded from 12 view on them (3). Based on their temporal appearance in HIV-1 infected macrophages (Fig. 2)  260 and the presence of budding profiles within membrane enclosed VCCs (our study and e.g. (21, 261 33)), we conclude that these accumulations can be formed internally. Importantly, this does not 262 exclude the possibility that viral assembly sites are initiated at the PM and are internalized before 263 the completion of release. In this context it is noteworthy that we also observed faint Gag at the 264 PM (Figs 1 and 2 ) and smaller punctuate Gag in close vicinity to the PM (Fig. 2C) , which could 265 resemble PM assembly or assembly sites at the beginning of internalization (22, 45) . 266
We also do not dismiss the possibility that some of the VCCs in macrophages might be connected 267 to the PM, e.g. by small microchannels (4, 9, 44, 45). Our results are in agreement with a recent 268 study by Welsch and colleagues (44). Using electron tomography and EM with stereology they 269 described a complex membranous network which harbours viral particles. These VCCs, which 270
were designated "HIV-1 assembly and storage compartments", were connected to the cell surface 271 by tube-like structures with insufficient diameter for virion passage. Therefore, it was postulated 272 that the nature of the virus holding compartment may aid in antibody evasion of HIV-1 (44). For 273 the first time our study provides experimental proof that macrophage internal HIV-1 is indeed 274 inaccessible to surface administered neutralizing antibodies. These results are based on the usage 275 of four different antibodies, either targeted against CD81, a component frequently found in VCCs 276 (our study and e.g. (9)) or against HIV-1 GP120. Notably, all three GP120 antibodies are directed 277 against the CD4 binding site of GP120 and were described as broadly neutralizing with no cross 278 reactivity against host self or other antigens (42, 46). Cell-to-cell spread of HIV-1 is far more efficient than infection by cell free virus (7, 10, 34) and 287
occurs via so called virological synapses (VS) (25). Macrophages have also been reported to 288 transmit HIV-1 via VS to T-cells (16, 43) and Freed and colleagues using a TC-tagged HIV 289 derivative showed rapid transfer of internal VCC from macrophages towards VS and T-cells (13). 290
The Sattentau lab reported that formation of the VS needs CD4 and to a smaller extent the 291 chemokine coreceptor on the target cell (16). In addition, transmitted virus was sensitive towards 292 fusion inhibitors and antibodies that bind CD4 and block interaction with GP120 (16, 24) . 293
Interestingly, cell free infection and cell-to-cell transfer could be suppressed by antibodies 294 targeting the HIV-1 glycoprotein, but this effect was only demonstrated for transfer between T-295 cells (24). Our findings suggest that GP120 antibody pretreated macrophages efficiently transfer 296 internal HIV-1 to T-cells (Fig. 5) . This is in agreement with a model in which HIV-1 at least in 297 part assembles into an internal niche. In this scenario, a large proportion of GP120 is not exposed 298 at the plasma membrane of macrophages, a finding which is supported by our surface GP120 299 staining of HIV-1 infected macrophages (Fig. 4) . In contrast, assembly in T-cells precedes 300 transport of GP120 to the plasma membrane, which could then be accessible to neutralizing 301
antibodies. 302
It is tempting to speculate that the complex membrane architecture of VCCs observed by us and 303
Welsch and colleagues (44) (Fig. 3A) . This is a 308 finding which is corroborated by data from Gag-CD81 coimmunoprecipitation experiments (15). 309
Interestingly, the tetraspanins CD9, CD63, CD81 and CD82 have been suggested as gateways for 310 HIV-1 in HeLa (28) and T-cells (15, 20) . Since tetraspanins are membrane associated and build 311 homo-as well as heteromers (41) it is tempting to speculate that Gag itself by the interaction with 312 CD81 and maybe other members of the tetraspanin family might directly be involved in the 313 formation of the membranous web. 314
In sum, this study emphasizes the potential importance of HIV-1 infected macrophages for viral 315 immune evasion and therefore AIDS pathogenesis. It is crucial to further elucidate the nature of 316 the membranous structures serving as HIV-1 storage compartment and hideout in order to target 317 the macrophage residing HIV-1 reservoir. 318
319

METHODS 320
Plasmids and proviral constructs. HIV-1 pUC-NL4-3 Gag-iGFP (18) and the R5-tropic HIV-1 321 pBR-NL4-3 92th014.12 (32) have been already described. For generation of an R5-tropic HIV-1 322
Gag-iGFP we excised and ligated the Gag-iGFP cassette using the single cutter restriction sites 323
BssHI and AgeI into the pBR-NL4-3 vector backbone. Subsequently we introduced the R5-tropic 324 V3-loop V92th014.12 (32) with the flanking restriction enzymes NheI and StuI. The same 325 strategy was used to construct a R5-tropic version of pBR-NL4-3 IRES-eGFP (36), termed pBR-326 NL4-3 V92th014.12-IRES-eGFP. To generate pBR-NL4-3 Gag-iCFP, CFP was amplified with 327 the primers Gag-iCFP_MluI (TCGACGCGTATGGTGAGCAAGGGCGAG) and Gag-328 iCFP_XbaI (ACGTCTAGACTTGTACAGCTCGTCCAT) and ligated into pUC-NL4-3 Gag-329 iGFP (18). In a second step, the Gag-iCFP fragment was ligated via BssHII and AgeI into the 330 pBR-NL4-3 V92th012.12 backbone. Mem-YFP and CD4-YFP have been described before (2). 331 The according ligation procedure has been described elsewhere (2). All PCR derived inserts were 342 sequenced to confirm sequence identity. of GFP+ cells was determined by standard FACS measurements, essentially as described before 371 (37). Macrophages were generated as described and seeded in a 24-well plate at a density of 372 50.000 cells/well. Post adherence macrophages were infected with 20 ng p24 of R5-tropic HIV-1 373 IRES-eGFP and cultured for additional six days. Then, cells were extensively washed to remove 374 free virus and incubated with 20 μg/ml anti-TfR or anti-GP120 2G 12 antibodies for one hour at 375 37°C. Post antibody removal macrophages were cocultured with 100.000 CemM7 cells/well for 376 ten hours. Subsequently CemM7 were collected by cold 5 mM EDTA/PBS and recultured in 500 377 μl RPMI for up to four days. 378 internalized antibody was detected as described above. For antibody internalization at 4 °C 392 macrophages were essentially treated the same, except that all steps were done on ice. Finally, 393 stained macrophages grown on coverslips were mounted on microscope slides using mowiol 394 mounting solution (2,4 g polyvinylalcohol, 6 g Glycerin, 18 ml PBS) and imaged with a Zeiss 395 LSM510 Meta. 396
Live cell microscopy. Live cell microscopy experiments were performed with a fully motorized 397
Nikon Ti-Eclipse inverted microscope equipped with the hardware based perfect focus system 398 and the Nikon DS-Qi1 high speed monochrome digital camera. If not indicated otherwise, 399 200.000 differentiated MDMs were seeded in a μ-Dish (35 mm high, Ibidi) and infected with 400 HIV-1 GG as described above. During image acquisition macrophages were kept in a microscope 401 desk mounted TokaiHit incubation chamber at 37 °C and 5 % CO 2 . If not indicated otherwise, the 402 on July 7, 2017 by guest http://jvi.asm.org/ Downloaded from
